Literature DB >> 12667572

Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction.

Pierre Théroux1, Robert C Welsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667572     DOI: 10.1016/s0002-9149(03)00020-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Low molecular weight heparin and atherosclerosis.

Authors:  Dan Hunt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

2.  Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.

Authors:  Malak El-Rayes; Erick Schampaert; Jean-Claude Tardif; Mark Jeffrey Eisenberg; Marc Afilalo; Simon Kouz; Claude Lauzon; Richard Harvey; Michel Nguyen; Remi Kouz; Jean-Pierre Dery; Samer Mansour; Anne-Marie Van Kieu; Stephane Rinfret; Thao Huynh
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

3.  Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  Xu-Kai Wang; Ye Zhang; Cheng-Ming Yang; Yan Wang; Guang-Yao Liu
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.

Authors:  Rober C Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; Willian S Weintraub; Pierre Theroux
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

Review 5.  Myocardial infarction (ST-elevation).

Authors:  Abel P Wakai
Journal:  BMJ Clin Evid       Date:  2009-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.